Different associations between organ-specific immune-related adverse event and survival in non-small cell lung cancer patients treated with programmed death-1 inhibitors-based combination therapy.

Ther Adv Med Oncol · 2023 · PMC10644755 · PMID 38028145

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In patients receiving anti-PD-1 combination chemotherapy, the response rate was slightly higher in patients who developed irAE, although the difference did not reach statistical significance ( Supplemental Figure 2C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.